| Primary |
| Blood Cholesterol Increased |
25.0% |
| Hypercholesterolaemia |
14.5% |
| Blood Cholesterol |
11.7% |
| Hypertension |
9.6% |
| Hyperlipidaemia |
9.2% |
| Acute Coronary Syndrome |
9.0% |
| Dyslipidaemia |
4.5% |
| Coronary Artery Disease |
3.5% |
| Diabetes Mellitus |
2.3% |
| Type 2 Diabetes Mellitus |
1.7% |
| Low Density Lipoprotein Increased |
1.4% |
| Gastrooesophageal Reflux Disease |
1.0% |
| Blood Triglycerides Increased |
1.0% |
| Atrial Fibrillation |
0.9% |
| Myocardial Infarction |
0.9% |
| Prophylaxis |
0.9% |
| Renal Transplant |
0.8% |
| Type Iia Hyperlipidaemia |
0.7% |
| Depression |
0.7% |
| Osteoporosis |
0.7% |
|
| Rhabdomyolysis |
27.9% |
| Myalgia |
16.2% |
| Pain |
8.3% |
| Pain In Extremity |
6.7% |
| Myocardial Infarction |
5.0% |
| Pancreatitis |
4.9% |
| Muscular Weakness |
4.0% |
| Vomiting |
3.6% |
| Muscle Spasms |
2.8% |
| Weight Decreased |
2.7% |
| Blood Creatine Phosphokinase Increased |
2.3% |
| Renal Failure |
2.2% |
| Drug Ineffective |
1.9% |
| Death |
1.7% |
| Hepatic Enzyme Increased |
1.7% |
| Renal Failure Acute |
1.7% |
| Wrong Technique In Drug Usage Process |
1.7% |
| Nausea |
1.6% |
| Pancreatitis Acute |
1.5% |
| Urinary Tract Infection |
1.5% |
|
| Secondary |
| Blood Cholesterol Increased |
19.0% |
| Hyperlipidaemia |
11.5% |
| Hypertension |
10.5% |
| Hypercholesterolaemia |
9.6% |
| Product Used For Unknown Indication |
7.0% |
| Drug Use For Unknown Indication |
6.7% |
| Blood Cholesterol |
5.3% |
| Coronary Artery Disease |
5.1% |
| Diabetes Mellitus |
3.7% |
| Dyslipidaemia |
3.6% |
| High Density Lipoprotein Decreased |
3.4% |
| Blood Triglycerides Increased |
2.3% |
| Cardiac Disorder |
2.1% |
| Depression |
2.1% |
| Type 2 Diabetes Mellitus |
1.6% |
| Osteoporosis |
1.5% |
| Pain |
1.5% |
| Low Density Lipoprotein Increased |
1.3% |
| Gastrooesophageal Reflux Disease |
1.1% |
| Hypothyroidism |
1.1% |
|
| Myalgia |
16.1% |
| Rhabdomyolysis |
12.0% |
| Muscle Spasms |
6.7% |
| Vomiting |
6.4% |
| Pain In Extremity |
6.0% |
| Drug Hypersensitivity |
4.9% |
| Muscular Weakness |
4.9% |
| Wrong Technique In Drug Usage Process |
4.9% |
| Drug Ineffective |
4.5% |
| Amyotrophic Lateral Sclerosis |
4.1% |
| Weight Decreased |
4.1% |
| Pain |
3.7% |
| Weight Increased |
3.4% |
| Myocardial Infarction |
3.0% |
| Nausea |
3.0% |
| Cerebral Haemorrhage |
2.6% |
| Palpitations |
2.6% |
| Urticaria |
2.6% |
| Acute Myeloid Leukaemia |
2.2% |
| Loss Of Consciousness |
2.2% |
|
| Concomitant |
| Product Used For Unknown Indication |
30.6% |
| Drug Use For Unknown Indication |
17.7% |
| Hypertension |
9.0% |
| Blood Cholesterol Increased |
5.8% |
| Diabetes Mellitus |
5.6% |
| Type 2 Diabetes Mellitus |
4.0% |
| Pain |
3.0% |
| Depression |
2.8% |
| Smoking Cessation Therapy |
2.6% |
| Gastrooesophageal Reflux Disease |
2.3% |
| Blood Cholesterol |
2.2% |
| Rheumatoid Arthritis |
2.1% |
| Atrial Fibrillation |
1.8% |
| Cardiac Disorder |
1.8% |
| Osteoporosis |
1.7% |
| Chronic Obstructive Pulmonary Disease |
1.5% |
| Insomnia |
1.5% |
| Anxiety |
1.5% |
| Asthma |
1.4% |
| Blood Pressure |
1.3% |
|
| Weight Decreased |
13.3% |
| Vomiting |
10.3% |
| Weight Increased |
8.7% |
| Myocardial Infarction |
7.4% |
| Nausea |
6.9% |
| Flushing |
5.8% |
| Drug Ineffective |
5.0% |
| Pruritus |
4.4% |
| Tremor |
4.3% |
| Vision Blurred |
3.8% |
| Pain |
3.5% |
| Somnolence |
3.3% |
| Type 2 Diabetes Mellitus |
3.2% |
| Pain In Extremity |
3.1% |
| Blood Glucose Increased |
3.0% |
| Urinary Tract Infection |
2.9% |
| Rash |
2.9% |
| Dyspnoea |
2.8% |
| Pancreatitis |
2.7% |
| Paraesthesia |
2.7% |
|
| Interacting |
| Hypertension |
11.1% |
| Diabetes Mellitus |
9.5% |
| Heart Transplant |
9.5% |
| Hypertriglyceridaemia |
9.5% |
| Helicobacter Infection |
7.9% |
| Hypercholesterolaemia |
6.3% |
| Blood Cholesterol Increased |
4.8% |
| Depression |
4.8% |
| Hyperlipidaemia |
4.8% |
| Angina Pectoris |
3.2% |
| Gout |
3.2% |
| Hypothyroidism |
3.2% |
| Migraine |
3.2% |
| Pain |
3.2% |
| Product Used For Unknown Indication |
3.2% |
| Prostate Cancer |
3.2% |
| Smoking Cessation Therapy |
3.2% |
| Thrombosis Prophylaxis |
3.2% |
| Antiandrogen Therapy |
1.6% |
| Arrhythmia Supraventricular |
1.6% |
|
| Rhabdomyolysis |
26.3% |
| Myopathy |
21.1% |
| Drug Interaction |
10.5% |
| Headache |
5.3% |
| Increased Appetite |
5.3% |
| Liver Function Test Abnormal |
5.3% |
| Overdose |
5.3% |
| Pain In Extremity |
5.3% |
| Renal Failure Acute |
5.3% |
| Sleep Disorder |
5.3% |
| Transaminases Increased |
5.3% |
|
